Berberine suppresses proinflammatory responses through AMPK activation in macrophages. 2009

Hyun Woo Jeong, and Kuan Chi Hsu, and Joo-Won Lee, and Mira Ham, and Jin Young Huh, and Hyun Jung Shin, and Woo Sik Kim, and Jae Bum Kim
Institute of Molecular Biology and Genetics, Department of Biological Sciences, Seoul National University, San 56-1, Sillim-Dong, Kwanak-Gu, Seoul 151-742, Korea.

Berberine (BBR) has been shown to improve several metabolic disorders, such as obesity, type 2 diabetes, and dyslipidemia, by stimulating AMP-activated protein kinase (AMPK). However, the effects of BBR on proinflammatory responses in macrophages are poorly understood. Here we show that BBR represses proinflammatory responses through AMPK activation in macrophages. In adipose tissue of obese db/db mice, BBR treatment significantly downregulated the expression of proinflammatory genes such as TNF-alpha, IL-1beta, IL-6, monocyte chemoattractant protein-1 (MCP-1), inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2). Consistently, BBR inhibited LPS-induced expression of proinflammatory genes including IL-1beta, IL-6, iNOS, MCP-1, COX-2, and matrix metalloprotease-9 in peritoneal macrophages and RAW 264.7 cells. Upon various proinflammatory signals including LPS, free fatty acids, and hydrogen peroxide, BBR suppressed the phosphorylation of MAPKs, such as p38, ERK, and JNK, and the level of reactive oxygen species in macrophages. Moreover, these inhibitory effects of BBR on proinflammatory responses were abolished by AMPK inhibition via either compound C, an AMPK inhibitor, or dominant-negative AMPK, implying that BBR would downregulate proinflammatory responses in macrophages via AMPK stimulation.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008820 Mice, Obese Mutant mice exhibiting a marked obesity coupled with overeating, hyperglycemia, hyperinsulinemia, marked insulin resistance, and infertility when in a homozygous state. They may be inbred or hybrid. Hyperglycemic Mice,Obese Mice,Mouse, Hyperglycemic,Mouse, Obese,Hyperglycemic Mouse,Mice, Hyperglycemic,Obese Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000263 Adenylate Kinase An enzyme that catalyzes the phosphorylation of AMP to ADP in the presence of ATP or inorganic triphosphate. EC 2.7.4.3. Myokinase,AMP Kinase,ATP-AMP Phosphotransferase,ATP-AMP Transphosphorylase,Adenylokinase,ATP AMP Phosphotransferase,ATP AMP Transphosphorylase,Kinase, AMP,Kinase, Adenylate,Phosphotransferase, ATP-AMP,Transphosphorylase, ATP-AMP

Related Publications

Hyun Woo Jeong, and Kuan Chi Hsu, and Joo-Won Lee, and Mira Ham, and Jin Young Huh, and Hyun Jung Shin, and Woo Sik Kim, and Jae Bum Kim
June 2010, Journal of cellular biochemistry,
Hyun Woo Jeong, and Kuan Chi Hsu, and Joo-Won Lee, and Mira Ham, and Jin Young Huh, and Hyun Jung Shin, and Woo Sik Kim, and Jae Bum Kim
January 2017, Oncotarget,
Hyun Woo Jeong, and Kuan Chi Hsu, and Joo-Won Lee, and Mira Ham, and Jin Young Huh, and Hyun Jung Shin, and Woo Sik Kim, and Jae Bum Kim
November 2016, The American journal of pathology,
Hyun Woo Jeong, and Kuan Chi Hsu, and Joo-Won Lee, and Mira Ham, and Jin Young Huh, and Hyun Jung Shin, and Woo Sik Kim, and Jae Bum Kim
December 2023, Environmental toxicology,
Hyun Woo Jeong, and Kuan Chi Hsu, and Joo-Won Lee, and Mira Ham, and Jin Young Huh, and Hyun Jung Shin, and Woo Sik Kim, and Jae Bum Kim
January 2024, Journal of immunology research,
Hyun Woo Jeong, and Kuan Chi Hsu, and Joo-Won Lee, and Mira Ham, and Jin Young Huh, and Hyun Jung Shin, and Woo Sik Kim, and Jae Bum Kim
February 2015, DNA and cell biology,
Hyun Woo Jeong, and Kuan Chi Hsu, and Joo-Won Lee, and Mira Ham, and Jin Young Huh, and Hyun Jung Shin, and Woo Sik Kim, and Jae Bum Kim
May 2022, Journal of cardiovascular pharmacology,
Hyun Woo Jeong, and Kuan Chi Hsu, and Joo-Won Lee, and Mira Ham, and Jin Young Huh, and Hyun Jung Shin, and Woo Sik Kim, and Jae Bum Kim
April 2013, Investigative ophthalmology & visual science,
Hyun Woo Jeong, and Kuan Chi Hsu, and Joo-Won Lee, and Mira Ham, and Jin Young Huh, and Hyun Jung Shin, and Woo Sik Kim, and Jae Bum Kim
December 2020, The FEBS journal,
Hyun Woo Jeong, and Kuan Chi Hsu, and Joo-Won Lee, and Mira Ham, and Jin Young Huh, and Hyun Jung Shin, and Woo Sik Kim, and Jae Bum Kim
July 2020, Molecules (Basel, Switzerland),
Copied contents to your clipboard!